Pediatrics Doctors in Visalia, CA Accepting Medicare
32 Pediatrics doctors found. Showing 21 - 32
 Dr. Ralph Kingsford, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 5400 W Hillsdale Ave, Visalia, CA 93291 Phone: 559-738-7500 Fax: 559-738-7560 |
 Sandhya Jitendra Kadam, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2333 S Mooney Blvd, Visalia, CA 93277 Phone: 877-960-3426 Fax: 559-734-1247 |
Side Xi, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2611 N Dinuba Blvd, Visalia, CA 93291 Phone: 559-733-6342 |
Rishika Sharma, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 31180 Road 72, Visalia, CA 93291 Phone: 877-960-3426 |
Dr. Elisabeth A Bossingham, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1827 S Court St, Suite F, Visalia, CA 93277 Phone: 559-622-0800 Fax: 559-622-0801 |
George Haworth Latta Iii, M.D. Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 400 W Mineral King Ave, Visalia, CA 93291 Phone: 800-717-5670 Fax: 866-757-9283 |
Dr. Syeda Nazish Azim, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 31180 Road 72, Visalia, CA 93291 Phone: 559-737-4700 Fax: 559-734-1247 |
Dr. Darinka T Shaw, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 400 East Oak Street, Visalia, CA 93291 Phone: 559-741-4500 Fax: 559-741-4502 |
Nidhiben P Doshi, M.D Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 400 E Oak Ave, Visalia, CA 93291 Phone: 877-960-3426 |
Dr. Michael Nagatani, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 5400 W Hillsdale Ave, Visalia, CA 93291 Phone: 559-738-7500 Fax: 559-738-7560 |
Dr. Ahmad Abdelaziz Aboaziza, M.D. Pediatrics - Neonatal-Perinatal Medicine Medicare: Medicare Enrolled Practice Location: 400 W Mineral King Ave, Visalia, CA 93291 Phone: 559-624-2245 |
Dr. Waldo N. Henriquez, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 501 North Bridge Street, Visalia, CA 93291 Phone: 559-734-1939 Fax: 559-734-4384 |
News Archive
New insights on DNA replication can help develop novel cancer treatments
A study by the Centre for Chromosome Biology at NUI Galway, Ireland, in partnership with the University of Zurich, has uncovered new insights into how the replication of DNA occurs which can be applied to help develop novel cancer treatments.
MIT researchers develop new way to model effects of cancer-causing genetic mutations
Sequencing the genomes of tumor cells has revealed thousands of genetic mutations linked with cancer. However, sifting through this deluge of information to figure out which of these mutations actually drive cancer growth has proven to be a tedious, time-consuming process.
FDA's warning over LABA medications for asthma: AANMA offers guidance
Today Allergy & Asthma Network Mothers of Asthmatics (AANMA) offered guidance to help patients understand recent Food and Drug Administration (FDA) warnings about Advair ® (fluticasone and salmeterol), Foradil ® (formoterol), Severent ® (salmeterol) and Symbicort ® (budesonide and formoterol), daily inhaled medications containing a long-acting beta agonist (LABA, a 12-hour bronchodilator).
Researchers exploit power of evolution to create new drug for use against heart disease
An international team of researchers led by the University of Leicester has "harnessed the power of evolution" to create a new drug for possible use against heart disease, inflammation and other illnesses.
FDA's PADAC supports approval of BREO ELLIPTA as once-daily inhaled treatment for COPD
GlaxoSmithKline plc and Theravance, Inc. today announced that the Pulmonary-Allergy Drugs Advisory Committee to the US Food and Drug Administration voted that the efficacy and safety data provide substantial evidence to support approval of BREO ELLIPTA as a once-daily inhaled treatment for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (9 for, 4 against) and also for the reduction of COPD exacerbations in patients with a history of exacerbations (9 for, 4 against).
› Verified 5 days ago
- 1
- 2(current)
Internal Medicine
Family Medicine
Psychiatry & Neurology
Emergency Medicine
Pediatrics
Obstetrics & Gynecology
Radiology
Anesthesiology
Surgery